OneSource
Jeff Wong serves as the Chief Business Officer at OneSource since July 2025. Previously, Jeff held the position of VP and Global Head of Sales for the Biologics Business Unit at Syngene International Limited from September 2023 to July 2025, contributing to integrated research and manufacturing services for various sectors. Prior to that, Jeff was the Global Partnerships and Strategic Alliance Leader at FUJIFILM Diosynth Biotechnologies, focusing on recombinant proteins and gene therapies from September 2022 to September 2023. Jeff also served as the Global Executive VP of Sales at Single Use Support GmbH earlier in 2022, providing expertise in single-use technologies for the biopharmaceutical market. Jeff's career began at Sartorius Stedim North America, Inc. as the Global Head of Key Account Management Group in the BioProcess Solutions Division from August 2019 to November 2021, leading commercial operations and key account management in the biopharmaceutical industry.
This person is not in any teams
This person is not in any offices
OneSource
1 followers
We are OneSource. The multimodal specialty pharma CDMO with end-to-end capabilities across tech platforms and therapeutic modalities. With three decades of experience in specialized drug development and manufacturing, we are able to consistently deliver comprehensive solutions efficiently and effectively across various technology platforms and therapeutic modalities. Our team of over 1,200 professionals, including more than 200 techno-commercial experts has one goal – to work closely with our partners and make their vision come to life. We’re here to change the way you think about CDMOs. We deliver your ambitions with agility and flexibility. Why? Because your success is our success. So here we are, the type of CDMO you didn’t know could possibly exist.